Cefepime Injection
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
WARNINGS AND PRECAUTIONS
Hypersensitivity Reactions
ADD or other beta-lactams.
ADD Exercise caution… if this... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - May 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
Caverject Impulse (alprostadil for injection)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
WARNINGS AND PRECAUTIONS
Needle Breakage
Needle breakage, with a portion of the needle remaining in the penis, has been... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - May 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
AUVI-Q Autoinjector (epinephrine injection, USP)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
WARNINGS AND PRECAUTIONS
INJECTION-RELATED COMPLICATIONS
Do not inject into buttock. Additionally, injection into the... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - May 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
Adrenalin (epinephrine injection, USP)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
WARNINGS AND PRECAUTIONS
Potential for Ophthalmic Injury from Adrenalin® 30 mL multiple-dose vial The Adrenalin® 30 mL... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - May 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
Dobutamine in 5% Dextrose Injection, USP in Flexible Plastic Containers
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
CONTRAINDICATIONS
Add ... or any of its components.
PRECAUTIONS
General
Bold sentence: “During the... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - May 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
Crestor (rosuvastatin calcium)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
CONTRAINDICATIONS
Replace bullets 3 and 4 with the following:
Pregnancy
Lactation. Limited data indicate... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - May 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
Zorvolex (diclofenac)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
New safety information pertaining to the risks of Cardiovascular Thrombotic Events, Heart Failure and Edema. In addition, some... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - May 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
Zipsor (diclofenac)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
New safety information pertaining to the risks of Cardiovascular Thrombotic Events, Heart Failure and Edema. In addition, some... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - May 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
Voltaren-XR (diclofenac)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
New safety information pertaining to the risks of Cardiovascular Thrombotic Events, Heart Failure and Edema. In addition, some... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - May 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
Voltaren Gel (diclofenac)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
New safety information pertaining to the risks of Cardiovascular Thrombotic Events, Heart Failure and Edema. In addition, some... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - May 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
Voltaren (diclofenac)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
New safety information pertaining to the risks of Cardiovascular Thrombotic Events, Heart Failure and Edema. In addition, some... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - May 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
Vioxx (rofecoxib)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
New safety information pertaining to the risks of Cardiovascular Thrombotic Events, Heart Failure and Edema. In addition, some... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - May 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
Vimovo (naproxen/esomeprazole magnesium)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
New safety information pertaining to the risks of Cardiovascular Thrombotic Events, Heart Failure and Edema. In addition, some... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - May 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
Treximet (naproxen and sumitriptan)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
New safety information pertaining to the risks of Cardiovascular Thrombotic Events, Heart Failure and Edema. In addition, some... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - May 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
Tivorbex (indomethacin)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
New safety information pertaining to the risks of Cardiovascular Thrombotic Events, Heart Failure and Edema. In addition, some... (Source: Drugs.com - Labeling Changes)
Source: Drugs.com - Labeling Changes - May 1, 2016 Category: Drugs & Pharmacology Source Type: alerts
